000 | 02497nim a2200565 a 4500 | ||
---|---|---|---|
001 | HST8204 | ||
003 | UkLoHST | ||
006 | m o h | ||
007 | cr nna|||||||| | ||
007 | sr |mnnnnnzne| | ||
008 | 201204s2020 enk|||||o||h||||||||eng d | ||
028 | 5 | 0 |
_a8204 _bHenry Stewart Talks |
035 | _a(UkLoHST)4467 | ||
040 |
_aUkLoHST _beng _cUkLoHST |
||
100 | 1 |
_aHolgate, S. T. _4spk |
|
245 | 1 | 0 |
_aUpdate on the SNG001 drug, an INFbeta therapy for COVID-19 _h[electronic resource] / _can interview with Stephen Holgate. |
246 | 3 | _aUpdate on the SNG001 drug, an INFβ therapy for COVID-19 | |
246 | 3 | _aUpdate on the SNG001 drug, an Interferon-beta therapy for COVID-19 | |
260 |
_aLondon : _bHenry Stewart Talks, _c2020. |
||
300 | _a1 online resource (1 streaming audio file (13 min.)). | ||
490 | 1 |
_aInterviews on Covid-19, _x2056-452X |
|
500 | _aAudio interview. | ||
500 | _aTitle from title frames. | ||
505 | 0 | _aContents: An overview of SNG001 therapy -- Findings of the phase 2 clinical trial -- Treatment potential at different stages of the disease -- Advantages of the treatment delivery mode and accessibility -- Potential use as a prophylaxis treatment -- Follow up clinical trials to be undertaken -- Other treatment settings for INFβ. | |
506 | _aAccess restricted to subscribers. | ||
538 | _aMode of access: World Wide Web. | ||
650 | 0 |
_aAntiviral agents _xDevelopment. |
|
650 | 0 | _aClinical trials. | |
650 | 0 |
_aCoronavirus infections _xChemotherapy. |
|
650 | 0 |
_aCOVID-19 (Disease) _xPrevention. |
|
650 | 0 |
_aCOVID-19 (Disease) _xTreatment. |
|
650 | 0 | _aInterferon. | |
650 | 2 |
_aAntiviral Agents _xadministration & dosage. |
|
650 | 2 | _aClinical Trials, Phase II as Topic. | |
650 | 2 |
_aCoronavirus infections _xdrug therapy. |
|
650 | 2 |
_aCoronavirus infections _xprevention & control. |
|
650 | 2 |
_aCOVID-19 _xdrug therapy. |
|
650 | 2 |
_aCOVID-19 _xprevention & control. |
|
650 | 2 |
_aInterferon-beta _xadministration & dosage. |
|
650 | 2 |
_aInterferon-beta _xtherapeutic use. |
|
650 | 2 | _aNebulizers and Vaporizers. | |
650 | 2 |
_aPneumonia, Viral _xdrug therapy. |
|
650 | 2 |
_aPneumonia, Viral _xprevention & control. |
|
650 | 2 | _aPrecision Medicine. | |
650 | 2 | _aSARS-CoV-2. | |
650 | 2 | _aTreatment Outcome. | |
830 | 0 |
_aHenry Stewart talks. _pBiomedical & life sciences collection. _pInterviews on Covid-19. |
|
856 | 4 | 0 | _uhttps://hstalks.com/bs/4467/ |
856 | 4 | 2 |
_uhttps://hstalks.com/bs/p/1060/ _3Series |
999 |
_c75895 _d75895 |